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Abstract
Background: Previous study shown that enzyme treated-rice bran effectively improved hypertension and glucose
intolerance in stroke-prone spontaneously hypertensive rat (SHRSP). However, dual fermentation of rice bran’s
efficacy against metabolic syndrome in SHRSP is still unknown.
Methods: Fermented rice bran (FRB) was prepared by dual fermentation of rice bran using fungi and lactic acid
bacteria. The effect of FRB on metabolic syndrome in stroke-prone spontaneously hypertensive rats (SHRSP) was
investigated by single and chronic supplementation.
Results: Dual fermentation of rice bran enriches the functional value of rice bran. Single-dose oral administration of FRB
(2 g/kg body weight) reduced systolic blood pressure; however, chronic supplementation with 5 % FRB (4 weeks)
significantly reduced both systolic and diastolic blood pressure. FRB supplementation improved leptin impairment and
increased serum adiponectin levels and angiotensin-converting enzyme inhibitory activity. Furthermore, FRB
supplementation improved glucose tolerance and insulin sensitivity as well as serum insulin levels. Lipid profiles were
also improved by the regulation of 5′ adenosine monophosphate-activated protein kinase activation. Moreover,
supplementation with FRB reduced the expressions of hepatic transcription factors such as liver X receptor alpha,
sterol regulatory element-binding protein 1c, and carbohydrate-responsive element-binding protein alpha, as well
as their target genes. In conclusion, dietary supplementation with FRB may lower hypertension and alleviate
metabolic syndrome.
Conclusion: Metabolic syndrome was better alleviated with FRB supplementation. We therefore suggest FRB as
an alternative medicine to reduce the risks of lifestyle-related diseases.
Keywords: Fermented rice bran, Metabolic syndrome, Adiponectin, Glucose tolerance, Angiotensin-converting
enzyme, Stroke-prone spontaneously hypertensive rat
Background
Metabolic syndrome is a multifactorial metabolic dis-
order characterized by hypertension, insulin resistance,
dyslipidemia, and impaired glucose homeostasis. Approxi-
mately 25.0 % of the adult population worldwide has been
diagnosed with metabolic syndrome. A recent meta-
analysis showed that metabolic syndrome is associated
with a 2-fold increase in cardiovascular outcomes [1, 2].
Several functional food candidates such as certain bever-
ages, fruits, vegetables, grains, legumes, herbs, and spices
are considered to prevent or moderate the lethal effects of
metabolic syndrome [3]. Therefore, new therapeutic ap-
proaches are required to intensively lower the healthcare
cost and better control the conditions associated with
metabolic syndrome.
Rice bran is a byproduct of the rice milling process and
a rich source of dietary fibre and various bioactive com-
pounds [4]. Dietary fibre and phenolic compounds from
rice bran are widely used to increase the functionalities of
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some foodstuffs and enhance their effects against chronic
diseases [5]. Supplementation with rice bran and its active
components has been shown to be effective against dyslip-
idemia in different animal models [6–8]. Thus, it is pos-
sible to derive an array of value-added products from rice
bran for health promotion. This is because several active
compounds such as oryzanols, tocopherols, tocotrienols,
phytosterols, and nucleotides have been identified in rice
bran [9–11]. Enzyme-treated rice bran has been shown to
be effective against chronic diseases in rat and mouse
models [12, 13]. For instance, a recent study showed that
protein hydrolysates from rice bran improved insulin
resistance in a mouse model [14]. Emerging evidence of
the chronic disease-fighting properties of rice bran has ad-
vanced the development of rice bran for human use as a
functional food and a dietary supplement [15].
Several techniques such as fermentation have been
used in biotechnological applications to enhance the
nutritional and functional values of rice bran to make the
latter more beneficial in the management of metabolic
syndrome. Previous studies have shown that rice bran
fermented with Saccharomyces cerevisiae has antistress
and antifatigue effects [16]. Furthermore, polysaccharides
extracted from rice bran have shown anticancer and anti-
defective effects by regulating immune responses, whereas
a water extract of fermented rice bran has shown an anti-
photoaging effect [17, 18]. Ferulic acid and phenolic com-
pounds isolated from rice bran have been shown to have
hypoglycemic effects in a mouse model of type 2 diabetes
[19]. Moreover, brown rice fermented with Aspergillus
oryzae can suppress sodium dextran sulfate-induced col-
itis [20]. It has been shown in other studies that rice bran
fractions improve glucose and lipid metabolism in animal
models of metabolic syndrome [21, 22]. However, the ef-
fects of fermented rice bran (FRB) in metabolic syndrome
have been examined in only a few studies.
In the present study, we prepared FRB, which has a
higher nutritional value and flavour and is more palatable
than non-fermented rice bran (Non-FRB), and estimated




AIN-93M standard diet components were purchased from
Wako Pure Chemical Industries, Ltd. (Osaka, Japan) and
Oriental Yeast Co., Ltd. (Tokyo, Japan). An angiotensin-
converting enzyme (ACE) inhibitory assay kit (ACE kit-
WST; Dojindo, Kumamoto, Japan) and an insulin assay
kit (Rat insulin ELISA kit; Morinaga Institute of Biological
Science, Inc., Yokohama, Japan) were used in this study.
Blood pressure (BP) was measured using the tail-cuff
method (without heating) with a BP meter (MK-2000;
Muromachi Kikai, Tokyo, Japan). Unless otherwise specified,
all the chemicals and solvents used were of analytical
grade. Rice bran was kindly provided from Sunbran
Company (Tendo, Japan).
Preparation of FRB
FRB was prepared by dual fermentation using fungi and
lactic acid bacteria. At the first stage, rice bran was
steamed and cooled to about 30 °C, after which a spore
solution of Aspergillus kawachii was inoculated at an
initial concentration of 106 spores/g of rice bran. The
rice bran was incubated at 30 °C in a fermentation
chamber for 44 h. The solid-state culture obtained was
designated as rice bran koji. A mixture of rice bran koji
and rice powder (2:1) was saccharified using a 4-fold
amount of water at 56 °C for 12 h, heated at 85 °C for
15 min, and then cooled to about 30 °C. At the second
stage, the saccharified culture solution was inoculated
with a mixture of lactic acid bacteria (Lactobacillus brevis,
Lactobacillus rhamnosus, and Enterococcus faecium) at a
concentration of 0.01 % (w/w). The solution was then
incubated at 37 °C overnight and then heated at 85 °C
for 15 min to obtain the FRB. The FRB solution was
then filtered and lyophilized. The lyophilized powder
was kept at −30 °C until use. Non-FRB was prepared
by the same procedure mentioned above without the
inoculation of the rice bran with fungi or lactic acid
bacteria. The macronutrients in FRB and Non-FRB
were analysed using conventional methods for food
analysis.
Measurement of total phenolic content
The total phenolic contents of FRB and Non-FRB were
determined colourimetrically using Folin-Ciocalteu re-
agent according to the procedure specified by Ainsworth
[23] but with slight modifications. Three grams of the
fresh samples were mixed with 30 ml of 70 % methanol.
The mixtures were vortex for 30 min. The mixtures
were then centrifuged at 1400 × g at 4 °C for 15 min and
the supernatants were collected. Repeated extraction
was done for 45 min and 90 min vortex. The superna-
tants were then pooled for analysis.
To measure the total phenolic content, 0.1-ml aliquots
of the extracts were mixed with 0.75 ml of 10-fold
diluted Folin-Ciocalteu reagent and allowed to stand at
25 °C for 10 min. Next, 0.75 ml of 2 % Na2CO3 was
added to each mixture and the solutions were allowed to
stand in the dark for 45 min at 25 °C. Absorbance was
then measured at 765 nm using a spectrophotometer.
Standard curves were plotted using standard catechin
and gallic acid solutions (Sigma-Aldrich Co., St. Louis,
MO, USA). Total phenolic content was expressed as the
gallic acid equivalents per gram of each sample of dried
rice bran.
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Animals
Male SHRSP/Izm rats were obtained from Japan SLC
(Hamamatsu, Japan) and used in the study. The rats
were kept in two-chambered individual stainless steel
cages in a controlled atmosphere (temperature: 23 ± 3 °C;
humidity: 50 ± 10 %; and a 12/12 h light–dark cycle). The
rats were given free access to AIN-93M standard rat diet
and drinking water for 1 week before the experiments.
The animal use and care protocols were reviewed and ap-
proved by the Animal Research-Animal Care Committee
of Tohoku University (Sendai, Japan).
Biochemical analyses
The serum levels of glucose, total cholesterol (TC), tri-
glycerides (TG), and high-density lipoprotein cholesterol
(HDL-C) were measured by enzymatic colorimetric
methods (Wako Pure Chemical Industries, Ltd.) according
to the manufacturer’s instructions. Serum levels of low-
density lipoprotein cholesterol (LDL-C) were calculated
using the Friedewald formula [(TC – HDL-C) – (1/5 ×
TG)]. Plasma adiponectin levels were measured using a rat
adiponectin ELISA kit (Otsuka Pharmaceutical Co., Ltd.,
Tokyo, Japan), whereas serum leptin levels were measured
using a rat leptin ELISA kit (Yanaihara Institute Inc.,
Fujinomiya, Japan). Liver TC and TG levels were mea-
sured with the same kits used for measuring the serum
TC and TG levels, following the extraction of liver sam-
ples with methanol/chloroform (1:2, v/v).
Single-dose oral administration study
Twelve 11-week-old male SHRSP/Izm rats were used in
this study. After the 1-week acclimatization period, the
rats were divided into 3 groups of 4 rats each and ad-
ministered FRB, Non-FRB, or water (control). FRB and
Non-FRB were administered at 2 g/kg body weight. Each
rat was deprived of food and water for 16 h before dose
administration. The body weight and initial systolic BP
of each rat were measured before and at 1, 2, 4, and 6 h
after dose administration. Six BP measurements were
taken for each rat. All the BP measurements in this
study were taken by the same person.
Chronic supplementation study
Eighteen, 9-week-old, male, body-weight-matched SHRSP/
Izm rats were used in this study. After the 1-week
acclimatization period, the rats were divided into 3 groups
of 6 rats each and supplied 5 % of FRB, Non-FRB, or water
(control) (Table 1) for 4 consecutive weeks. Food intake
and body weight were measured every other day and
weekly, respectively. Systolic, diastolic, and mean arterial
blood pressure were measured weekly.
After the 4 weeks of chronic supplementation with the
various treatments, each rat was sacrificed by direct de-
capitation. Blood was collected and allowed to coagulate
for 30 min, after which serum was obtained by centrifu-
ging the coagulated blood at 1400 × g for 15 min. The
serum samples were stored at −20 °C for measurements
later. The livers were collected and dissected immedi-
ately after sacrifice, washed with normal saline, frozen in
liquid nitrogen, and stored at −80 °C until analysis.
Oral glucose tolerance test (OGTT) and insulin tolerance
test (ITT)
The OGTT was conducted when the rats were 13 weeks
old. The test was done after fasting the rats for 16 h.
Blood samples were collected from the tail vein before
and at 30, 60, and 120 min after the oral administration
of glucose (1.8 g/kg body weight) to each rat via a gastric
tube. The levels of glucose and insulin in plasma were
then analysed. Area under the curve (AUC) was calcu-
lated based on a previously published method [24].
The animals were subjected to the ITT 3 days before
they were sacrificed and after a 5-h fast. Blood samples
were collected from the tail vein before and at 30, 60,
and 120 min after the rats were administered human
insulin (Humulin R 100 IU/ml; Eli Lilly and Company,
Indianapolis, IN, USA) intraperitoneally (0.6 U/kg body
weight). Glucose levels in the plasma samples were then
measured.
Measurement of ACE inhibitory activity
The ACE inhibitory activities of FRB and Non-FRB were
determined according to a previously published method
[25]. Briefly, enzyme and indicator working solutions
were prepared according to the manufacturer’s instruc-
tions. Aliquots of serum (20 μl) were placed in the wells
of a 96-well microplate. Next, 20 μl and 40 μl of deionized
water were added for the ‘blank1’ and ‘blank2’ wells, re-
spectively. Afterwards, 20 μl of substrate buffer was added
to each well, followed by the addition of 20 μl of enzyme
Table 1 Composition of experimental diets
Ingredient (g/kg) Control Non-FRB FRB
Corn starch 602.65 589.65 589.65
Casein 140.5 133 133
Sucrose 95 95 95
Cellulose 58.5 47.5 47.5
Soybean oil 43 38 38
Mineral mixture 38.25 33.25 33.25
Vitamin mixture 9.5 9.5 9.5
Choline bitartrate 2.37 2.375 2.375
L-Cystine 1.71 1.71 1.71
tert-Butylhydroquinone 0.0076 0.0076 0.0076
Test material 8.5 (water) 50.0 50.0
Total 1000 1000 1000
FRB fermented rice bran, Non-FRB non-fermented rice bran
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working solution to the experimental wells and blank1.
The plate was then incubated at 37 °C for 1 h. After incu-
bation, 200 μl of indicator working solution was added to
each well and the plate was incubated again at 25 °C for
5 min. Absorbance was measured at 450 nm using a spec-
tral microplate auto-reader. ACE inhibitory activity was
calculated using the following equation:
ACE inhibitory activity % Inhibition rateð Þ
¼ Ablank1–Asample
 
= Ablank1–Ablank2ð Þ  100
RNA preparation and quantitative reverse transcription
polymerase chain reaction (RT-PCR)
Total RNA was isolated from the liver tissues of the rats
using a guanidine isothiocyanate-based reagent (Isogen;
Nippon Gene, Tokyo, Japan) according to the manufac-
turer’s instructions. After isolating the total RNA, the
ratio at wavelength of 260 and 280 nm was measured.
Agarose gel electrophoresis was performed to expedite
the quantitative and qualitative analyses of the isolated
RNA. Four micrograms of RNA was used as a template
to synthesize cDNA as previously described [21]. Aliquots
of the obtained cDNA were then used as templates for the
subsequent quantitative PCR using an Applied Bioscience
(Foster City, CA, USA) 7300 real-time PCR system. The
relative gene expression levels were normalized to the
amount of eukaryotic elongation factor-1α1 mRNA. The
genes were amplified using cDNA specific primers. The fol-
lowing primers were used: glucose-6-phosphatase catalytic
subunit (G6PC): TTGTGCATTTGCTAGGAAGAGAAG
(forward) TCTAAAGACCCAGGCATAACTGAAG (re-
verse); phosphoenolpyruvate carboxykinase (PEPCK): GAG
GACATTGCCTGGATGAAGTTT (forward) TGGGTTG
ATGGCCCTTAAGT (reverse); fatty acid synthase (FASN):
GGCTCACACACCTACGTATTGG (forward) TGCTTAA
TGAAGAAGCATATGGCTT (reverse); acetyl-CoA carb-
oxylase (ACC): TTGTGGAAGTGGAAGGCACAG (for-
ward) CCTTATTATTGTCCCAGACGTAAGC (reverse);
stearoyl-CoA desaturase-1 (SCD1): CTGGAGATGGGA
GCCACAAG (forward) CAGGAACTCAGAAGCCCA
GAA (reverse); 3-hydroxy-3-methylglutaryl-CoA reductase
(HMGCR): AATTGTGTGTGGCACTGTGATG (forward)
GATCTGTTGTGAACCATGTGACTTCT (reverse); sterol
regulatory element-binding protein 1c (SREBP-1c): GGAG
CCATGGATTGCACATT (forward) GCTTCCAGAGAG
GAGCCCAG (reverse); Carbohydrate response element
binding protein alpha (ChREBPα): CGACACTCACCCAC
CTCTTC (forward) TTGTTCAGCCGGATCTTGTC (re-
verse); liver X receptor alpha (LXRα): ACCTCTGCGATCG
AGGTGAT (forward) AAAGTCTTCCGGGTTGTAACT




The rat livers were homogenized in phosphate-buffered
saline containing protease (cOmplete protease inhibitor
cocktail; Roche Applied Science, Mannheim, Germany)
and phosphatase (PhosSTOP phosphatase inhibitor cock-
tail, Roche Applied Science) inhibitors. The protein concen-
trations in the lysates were measured using a protein assay
reagent (Bio-Rad, Hercules, CA, USA). Afterwards, 7.5 μg
of protein in sodium dodecyl sulfate (SDS) gel loading
buffer was resolved on a 10–20 % SDS-polyacrylamide gel.
The separated proteins were transferred onto Immobilon-P
membrane (Millipore, Billerica, MA, USA). The membrane
was incubated with a blocking buffer (10 mmol/l Tris–HCl
at pH 7.4, 150 mmol/l HCl, 0.1 % Tween 20, and 5 %
bovine serum albumin) for 1 h. Next, the membrane was
incubated overnight with the blocking buffer containing
antibodies against AMP-activated protein kinase (AMPK)-
α1 (Millipore) at a dilution of 1:10,000 and antibodies
against p-AMPKα (Thr 172; Millipore) at a dilution of
1:5000. Immobilon western detection reagent (Millipore)
was used with a luminescent image analyser (LAS-4000
mini; Fujifilm, Tokyo, Japan). The relative expression levels
of each protein were normalized according to the amount
of α-tubulin (Sigma-Aldrich Co.) detected by the antibody
against the protein.
Statistical analysis
Data are represented as mean ± standard error of the
mean (SEM). Statistical analysis was performed by one-way
analysis of variance followed by Tukey’s multiple compari-
son test. The analysis was performed using SigmaPlot soft-
ware version 12.5 (San Jose, CA, USA). A P value < 0.05
was considered statistically significant.
Results
Macronutrients in FRB and Non-FRB
The dual fermentation process improved on the character-
istic flavour and macronutrient composition of the rice
bran (Table 2). The results show that the lipid, dietary
fibre, and total phenolic contents of FRB are higher than
Table 2 Analysis of macronutrients in fermented and non-
fermented rice bran




Dietary fibre 4.4 22.0
Ash 8.8 10.0
Carbohydrate 49.3 13.1
Total phenolic content 6.5 8.6
Total phenolic content was calculated as the gallic acid equivalent per gram of
dried rice bran. FRB fermented rice bran, Non-FRB non-fermented rice bran
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those of non-FRB. These indicate that the fermentation
process enhanced the natural flavour and the chemical
and secondary metabolite content of the rice bran.
Effect of FRB after a single-dose oral administration
Rats that had systolic BP of approximately 175 mm/Hg were
used to investigate whether or not ingesting FRB at a single
oral dose of 2 g/kg body weight produces an antihyperten-
sive effect (Fig. 1a). The mean systolic BP of the control
group was almost constant for 6 h and slightly decreased
afterwards. A BP lowering effect was observed at 1, 2, and
4 h after the administrations of FRB and Non-FRB to the
SHRSP. However, after 6 h, BP lowering was constant in the
FRB group, and similar in the Non-FRB and control groups.
The maximum reduction in BP observed was approximately
35 mmHg and it occurred in the FRB group from 1 to 4 h
after dose administration. The effects of the single oral dose
of FRB on blood glucose and insulin levels are shown in
Fig. 1b and c, respectively. Two hours after administering
the single dose FRB, there was a reduction in plasma glucose
than that in the control group. In addition, plasma insulin
levels tended to decrease in both the FRB and Non-FRB
groups. However plasma TC and TG levels were the same
values in all the groups (data not shown).
Antihypertensive effect of FRB after chronic
supplementation
Chronic supplementation with either FRB or Non-FRB
decreased BP elevation of the rats (Fig. 2a, b, and c).
Systolic, diastolic, and mean BP significantly decreased
throughout the experiment in the FRB group but BP
elevation remained constant in the control group. Non-
FRB reduced diastolic BP from the second week of the
experiment; however, reduction in diastolic BP was con-
sistent in the FRB group throughout the experiment. At
the end of the experiment, the mean systolic BP was
181 ± 3.6, 149 ± 4.3, and 138 ± 4.4 mmHg for the control,
Non-FRB, and FRB groups, respectively. Furthermore,
serum ACE inhibitory activity was significantly higher in
the FRB group than in the control group whereas Non-
FRB group had no significant difference (Fig. 2d). The re-
sults obtained indicate that FRB has a hypotensive effect.
Effect of chronic supplementation with FRB on growth,
liver, and serum parameters in SHRSP
Chronic supplementation with FRB significantly reduced
food intake, body weight, and epididymal fat mass (Table 3).
No differences were observed in the kidney and heart
weights; however, liver weight showed a tendency to reduce
(data not shown). FRB significantly improved glucose
tolerance as well as the AUC of glucose and insulin
(Fig. 3a and b). In addition, FRB improved insulin resist-
ance by reducing the insulin resistant index, HOMA-IR
(homeostatic model assessment of insulin resistance), as
well as glucose levels after ITT (Fig. 3c and d). Table 3
summarizes the serum, liver, and growth parameters
measured in this study. After 4 weeks of chronic sup-





















































Fig. 1 Effects of a single-dose oral administration of FRB in SHRSP. (a) Systolic blood pressure (SBP), (b) plasma glucose, and (c) insulin levels 2 h
after FRB administration. All data are presented as mean ± SEM (n = 4). *, # P < 0.05 compared to control, Non-FRB. FRB fermented rice bran, Non-FRB
non-fermented rice bran, SEM standard error of the mean, SHRSP stroke-prone spontaneously hypertensive rats
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insulin reduced. At the end of the study, FRB had
significantly lowered hepatic TG and TC levels. In
addition, serum TG and TC levels were lower in the
FRB group than in the control group. Supplementation
with FRB caused a significant increase in serum adipo-
nectin (both high molecular weight and total adiponec-
tin) levels and a significant decrease in serum fasting
leptin levels. Moreover, FRB supplementation increased
leptin sensitivity and subsequently decreased the leptin/
adiponectin ratio.
Effect of FRB on hepatic gene expression and AMPK
activation
The mRNA expression levels of LXRα, SREBP-1c, and
ChREBPα in the liver were measured to clarify how FRB
ameliorates metabolic syndrome in SHRSP. After chronic
supplementation with FRB, the relative mRNA expression
levels of the aforementioned transcription factors and
their target genes such as G6PC, PEPCK, FASN, ACC,
SCD1, and HMGCR were suppressed (Fig. 4). Moreover,
quantitative western blot analysis showed that FRB signifi-
cantly increased p-AMPK/AMPK ratio as well as phos-
phorylation of p-AMPKα in the liver (Fig. 5). Thus, FRB
may activate the AMPK signalling pathway in the liver.
Discussion
This study is the first to demonstrate that dual fermentation
of rice bran enriches the functional ingredients in rice bran.
FRB therefore contains higher levels of lipid, dietary fibre,
and phenolic compounds more than Non-FRB does
(Table 2). The results obtained from this study indicate that
FRB improves hypertension, insulin resistance, glucose im-
pairment, serum adiponectin level, and AMPK activation in
SHRSP. Thus, FRB may be a potent functional food that
can be used for the management of metabolic syndrome.
Adiponectin is an important adipokine for insulin
sensitization and is involved in some homeostatic functions
such as the regulation of glucose and lipid metabolism [26].
A recent study showed that antihypertensive drugs could
improve the sensitivities of adiponectin and leptin in
SHRSP [27]. In the present study, FRB improved adipo-
nectin and leptin impairments in SHRSP, which results
in an improvement in glucose and lipid metabolism.
Plasma adiponectin levels are inversely related to adiposity
and directly associated with leptin sensitivity [28]. Thus, it
appears that FRB exerted its action on leptin sensitivity and
body fat mass via the stimulation of adiponectin secretion
even though the exact mechanisms involved are still
unknown.
Phenolic compounds and dietary fibre are used in
formulating food products to improve the functional-
ities and health benefits of such products. Phenolic
compounds and dietary fibre produce health benefits
by reducing cholesterolemia, modifying glycemic re-
sponses, and preventing the development of cardiovas-



















































































Fig. 2 Effects of chronic supplementation with FRB on blood pressure in SHRSP. (a) Systolic blood pressure (SBP), (b) diastolic blood pressure
(DBP), (c) mean blood pressure (MBP), and (d) serum angiotensin-converting enzyme (ACE) inhibitory activity after 4 weeks of FRB supplementation.
All data are presented as mean ± SEM (n = 6). *, # P < 0.05 compared to control, Non-FRB. FRB fermented rice bran, Non-FRB non-fermented rice bran,
SEM standard error of the mean, SHRSP stroke-prone spontaneously hypertensive rats
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brewing and food industries to produce fermented
products. They are also used to produce aroma com-
pounds and secondary metabolites for use in proc-
essed foods. Our results confirm that FRB is a
functional food that can be effective in the manage-
ment of metabolic syndrome and for the prevention of
lifestyle-related diseases.
We observed that after administration, a single oral
dose of FRB (2 g/kg body weight) lowers BP within 6 h.
We also found that FRB has the capacity to decrease
plasma glucose and insulin levels (Fig. 1). Chronic sup-
plementation with 5 % FRB for 4 weeks increased serum
ACE inhibitory activity (Fig. 2). This corroborates the re-
sults in a previous report, which indicated that fractions
of enzyme-treated rice bran improved BP elevation in
SHRSP via the inhibition of ACE activity [21]. Further-
more, FRB supplementation enhanced serum adiponectin
levels (both high molecular weight and total adiponectin)
and improved serum and liver lipid profiles (Table 3). FRB
supplementation also improved glucose tolerance and in-
sulin resistance (Fig. 3). It was shown in a previous study
that L-tryptophan, which is one of the identified functional
ingredients in enzyme-treated rice bran, improved blood
pressure as well as blood glucose and insulin levels [31]. It
was observed that the L-tryptophan content of FRB
(30 mg/100 g) is much higher than that of Non-FRB
(4 mg/100 g). In the liver, there is de novo glucose synthesis
mainly from lactate, alanine, pyruvate, and glycerol. In the
present study, FRB reduced the mRNA levels of enzymes
involved in gluconeogenesis (PEPCK and G6PC), which
are the rate limiting enzymes in gluconeogenesis. Insulin
can inhibit the transcriptional activity of forkhead box pro-
tein O1, which regulates the transcription of PEPCK. The
aforementioned mechanisms were therefore involved in
the improvements in serum glucose and insulin levels by
FRB in this study. Studies have shown that brown rice bran
and enzyme-treated rice bran improve glucose tolerance
and insulin resistance in mouse and rat models [21, 32].
Altogether, our results suggest that FRB regulates glucose
and lipid metabolism and contributes effectively to improv-
ing hypertension in SHRSP better than Non-FRB does.
Moreover, we observed that LXRα, SREBP-1c, and
ChREBPα mRNA expression levels were downregulated
after FRB supplementation in the SHRSP. Glucose and
insulin coordinate hepatic lipogenesis and the glycolytic
gene expression [33]. Both glucose and insulin are
Table 3 Effects of fermented and non-fermented rice bran on growth, serum, and liver parameters
Parameters Control Non-FRB FRB
Growth
Cumulative food intake (g) 398.18 ± 14.73 353.49 ± 32.05 311.63 ± 11.33*
Body weight gain (g) 81.21 ± 2.17 77.95 ± 2.91 71.18 ± 3.16*#
Epididymal fat mass (g/100 g BW) 1.99 ± 0.03 2.10 ± 0.04 1.72 ± 0.08*#
Serum
Glucose (mmol/l) 11.17 ± 0.95 7.99 ± 0.40* 8.31 ± 0.32*
Insulin (ng/ml) 4.49 ± 0.35 3.42 ± 0.43 2.28 ± 0.19*
AST (IU/l) 187.33 ± 6.96 231.50 ± 16.40* 189.33 ± 8.04#
TC (mg/dl) 80.00 ± 5.50 74.00 ± 2.03 76.17 ± 2.49
TG (mg/dl) 87.50 ± 3.33 89.33 ± 9.20 73.50 ± 5.94
LDL-C (mg/dl) 33.83 ± 4.45 27.63 ± 1.07 32.63 ± 2.14
HDL-C (mg/dl) 28.67 ± 1.33 28.50 ± 0.62 28.83 ± 0.87
Non-fasting leptin (ng/ml) 1.35 ± 0.10 1.88 ± 0.15 3.46 ± 2.60
Fasting leptin (ng/ml) 0.95 ± 0.08 0.78 ± 0.07 0.52 ± 0.05*
Leptin sensitivity (%) 28.35 ± 6.22 51.48 ± 6.75 59.55 ± 9.52*
High molecular adiponectin (μg/ml) 0.85 ± 0.04 1.01 ± 0.06 1.01 ± 0.03*
Total adiponectin (μg/ml) 8.70 ± 0.15 8.24 ± 0.14 9.092 ± 0.12#
Leptin/adiponectin ratio 0.11 ± 0.01 0.09 ± 0.01 0.05 ± 0.01*
Liver
Liver TG (mg/g tissue) 24.05 ± 0.78 23.95 ± 3.44 13.75 ± 2.09*
Liver TC (mg/g tissue) 3.25 ± 0.21 2.92 ± 0.31 1.61 ± 0.22*
Total lipid (mg/g tissue) 82.71 ± 18.26 78.99 ± 6.14 60.69 ± 11.47
Values are presented as means ± SEM, (n = 6). *, # P < 0.05 compared to control, Non-FRB. AST aspartate aminotransferase, BW body weight, FRB fermented rice
bran, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Non-FRB non-fermented rice bran, TC total cholesterol, TG triglycerides
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potent factors that are involved in inducing the tran-
scription of key enzyme genes in glycolysis and de novo
lipogenesis [34]. It has been found that rice bran deriva-
tives reduce plasma and liver lipids, whereas protein hy-
drolysates from rice bran improve insulin and leptin
sensitivity in high-fat diet-induced metabolic syndrome
in hamsters [6, 14]. Insulin triggers the transcriptions of
glycolytic and lipogenic enzymes by activating SREBP-1c
and LXRα [35, 36]. Therefore, chronic supplementation
with FRB downregulated the mRNA expression levels of
LXRα, SREBP-1c, and ChREBPα, as well as their target
genes such as G6PC, PEPCK, HMGCR, FASN, SCD1,
and ACC in the liver (Fig. 4). Thus, the decreased serum
glucose and liver TG levels due to the intake of FRB may
Fig. 3 Effects of FRB on plasma glucose and insulin levels. a Plasma glucose levels after oral glucose tolerance test (OGTT) (left) and the resulting
area under the curve (right). b Plasma insulin levels after OGTT (left) and the resulting area under the curve (right). c Plasma glucose levels
after insulin tolerance test (ITT). d Homeostatic model assessment of insulin resistance (HOMA-IR) index. Values are expressed as mean ± SEM
(n = 6). *, # P < 0.05 compared to control, Non-FRB. FRB fermented rice bran, Non-FRB non-fermented rice bran, SEM standard error of the mean

































Fig. 4 Effects of FRB on hepatic gene expression. ACC acetyl-CoA carboxylase, ChREBPα carbohydrate-responsive element-binding protein alpha,
FASN fatty acid synthase, G6PC glucose-6-phosphatase catalytic subunit, HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase, LXRα liver X receptor
alpha, PEPCK phosphoenolpyruvate carboxykinase, SCD1 steroyl-CoA desaturase-1, SREBP-1c sterol regulatory element-binding protein 1c. Values
are expressed as mean ± SEM (n= 6). *, # P< 0.05 compared to control, Non-FRB. FRB fermented rice bran, Non-FRB non-fermented rice bran, SEM standard
error of the mean
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have been caused by an enhanced serum level of adiponec-
tin, which regulates glucose and lipid metabolism.
FRB increased the activation of AMPK in the liver
(Fig. 5) and quantitative western blot analysis showed
that FRB increased the phosphorylation of AMPKα. This
indicates that FRB may activate the adiponectin/AMPK
signalling pathway. A study in humans has shown that
plasma adiponectin concentration negatively correlates
with lipid metabolism [37]. However, a previous study
demonstrated that the phosphorylation and activation of
AMPK are stimulated by adiponectin in the liver. The
study also indicated that adiponectin improved insulin
sensitivity and decreased plasma glucose levels via the
AMPK-peroxisome proliferator-activated receptor gamma
coactivator 1-alpha signalling pathway in the liver [38].
The results of the current study verified that the intake
of FRB could increase plasma adiponectin levels. This
results in an activation of AMPK and a downregulation
of the mRNA expression of genes involved in gluconeo-
genesis and lipogenesis in the liver. This suggests that
enhancing serum adiponectin levels and downregulating
transcription factors involved in hepatic glucose and fat
metabolism may be a promising strategy to prevent
metabolic-related diseases characterized by insulin re-
sistance and hyperlipidemia. Therefore, dietary supple-
mentation with FRB can mitigate metabolic syndrome.
Conclusions
Our results clearly indicate that dual fermentation of rice
bran with Aspergillus kawachii and lactic acid bacteria en-
riches the functional value of rice bran. This is because
metabolic syndrome was better alleviated with FRB sup-
plementation than with Non-FRB supplementation. FRB
effectively reduced BP by increasing serum ACE inhibitory
activity. FRB also increased serum adiponectin levels and
improved glucose and lipid metabolism. We therefore
suggest FRB as an effective functional food to reduce the
risks of lifestyle-related diseases. Further studies are how-
ever needed to elucidate the complete physiological effect
of FRB and confirm its detailed mechanism of action at
the molecular level.
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Fig. 5 Effects of FRB on AMPKα2 and p-AMPKα levels. (a) AMPKα2 and (b) p-AMPKα protein levels from quantitative western blot analysis.
c p-AMPKα/AMPKα2 ratio. Data were normalized with α-tubulin. Values are expressed as mean ± SEM (n = 3–4). *, # P < 0.05 compared to
control, Non-FRB. AMPK AMP-activated protein kinase, FRB fermented rice bran, Non-FRB non-fermented rice bran, SEM standard error of
the mean
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